|
Volumn 23, Issue 13, 1996, Pages 1825-1832
|
Late phase II study of LY188011 (gemcitabine hydrochloride) in patient with non small cell lung cancer
a a a a a a a a a |
Author keywords
Gemcitabine; Late phase II study; Non small cell lung cancer
|
Indexed keywords
GEMCITABINE;
ADULT;
AGED;
ANEMIA;
ANOREXIA;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
CANCER CHEMOTHERAPY;
CLINICAL TRIAL;
DRUG EFFICACY;
DRUG SAFETY;
HUMAN;
LEUKOPENIA;
LUNG NON SMALL CELL CANCER;
MAJOR CLINICAL STUDY;
MALAISE;
NAUSEA;
NEUTROPENIA;
PHASE 2 CLINICAL TRIAL;
ADENOCARCINOMA;
ADULT;
AGED;
ANOREXIA;
ANTIMETABOLITES, ANTINEOPLASTIC;
CARCINOMA, LARGE CELL;
CARCINOMA, NON-SMALL-CELL LUNG;
CARCINOMA, SQUAMOUS CELL;
DEOXYCYTIDINE;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
FEVER;
HEMOGLOBINS;
HUMANS;
INFUSIONS, INTRAVENOUS;
LEUKOPENIA;
LUNG NEOPLASMS;
MALE;
MIDDLE AGED;
NAUSEA;
NEUTROPENIA;
VOMITING;
|
EID: 0029979707
PISSN: 03850684
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (18)
|
References (0)
|